Vizora日本語

Nippon ShinyakuNippon Shinyaku Co.,Ltd.4516東証プライム医薬品FY ending Mar 2024, consolidated, IFRS

Nippon Shinyaku FY ending Mar 2020 results

About 87% of Nippon Shinyaku's sales come from Pharmaceuticals, with Functional Food making up much of the rest.

Out of every ¥100 of sales, about ¥19 is left as operating profit.

Where the money goes

Where ¥100 of sales goes

For every ¥100 Nippon Shinyaku sells, how much goes where, and how much is kept.

FY ending Mar 2020
Cost of sales
¥45
SG&A
¥36
Operating profit
¥19
Net profit kept
¥14

Margin funnel (derived from reported values)Gross margin 54.4% → Operating margin 18.6% → Net margin 14.5%

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Mar 2020
  • Pharmaceuticals¥101.6B
    87%
    Op. margin 20.4%
  • Functional Food¥15B
    13%
    Op. margin 6.5%

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (3)

  • EDINET (FSA Japan)

    有価証券報告書－第161期(2023/04/01－2024/03/31)

    ID S100TXM62024-06-28Open

  • EDINET (FSA Japan)

    有価証券報告書－第159期(令和3年4月1日－令和4年3月31日)

    ID S100OM322022-06-30Open

  • EDINET (FSA Japan)

    訂正有価証券報告書－第158期(令和2年4月1日－令和3年3月31日)

    ID S100LX4O2021-07-02Open

Extracted from XBRL: 44 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image